SCHEMBL19903604

SCHEMBL19903604

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(-n2c3ccc(C)cc3c3cc(C)ccc32)cc1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
NCOA1 Q15788 1/20 0.34
HIF1A Q16665 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
HTR6 P50406 2/20 0.32
HRH1 P35367 1/20 0.32
KIF11 P52732 1/20 0.32
TSHR P16473 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
PGR P06401 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19903530 0.96 AR (0.34) ARSMN1; SMN2CTSSCTSKLMNA
SCHEMBL19912387 0.95 AR (0.35) ARSMN1; SMN2CTSSCTSKLMNA
SCHEMBL22822508 0.94 RXRA (0.36) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19912425 0.92 KIF11 (0.36) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19917917 0.92 AR (0.44) ARCTSSCTSKKIF11PGR
SCHEMBL19903579 0.92 AR (0.36) ARSMN1; SMN2CTSSCTSKLMNA
SCHEMBL19912413 0.92 AR (0.35) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL22822134 0.92 KIF11 (0.36) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19903531 0.91 AR (0.36) ARSMN1; SMN2CTSSCTSKLMNA
SCHEMBL22564470 0.91 RXRA (0.34) ARHTTHTR6HRH1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-9917270-B1 Organic electroluminescent device having an exciton quenching layer CYNORA GMBH (DE) 2018-03-13 US disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 AR 4190/4885SMN1; SMN2 4423/4885CTSS 4248/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 AR 4212/4885SMN1; SMN2 4419/4885CTSS 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.